MYRCLUDEX B

Welcome to the Brand page for “MYRCLUDEX B”, which is offered here for Pharmaceuticals and pharmaceutical preparations for the treatment of infectious diseases, viral disease; vaccines; pharmaceutical preparations, preparations for the treatment of chronic hepatitis b (hbv) and hepatitis d (hdv);pharmaceutical services, pharmaceutical and medical counseling, provided in-person and via the internet; information and counseling relating to diagnostic, preventive and therapeutic properties of pharmaceuticals; information and counseling relating to diagnosis and treatment of infections, including information and counseling services provided online via a computer network or the internet;b;medical research; research for and development of vaccines and pharmaceuticals and pharmaceutical preparations for the treatment of infectious diseases and viral diseases, including hepatitis b (hbv) and hepatitis d (hdv), for others;.

Its status is currently believed to be active. Its class is unavailable. “MYRCLUDEX B” is believed to be currently owned by “Universitätsklinikum Heidelberg, Anstalt des öffentlichen Rechts”.